Skip to content

ARS Pharmaceuticals, Inc.

SPRY· NasdaqCore metricsCIK 1671858

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.67%
Market cap
$382.51M
100.53M shares
Filings
550
$37.71M
Q3 2026−5.5% FY25 yoy
-$35.59M
Q3 2026N/M FY25 yoy
-$34.17M
Q3 2026N/M FY25 yoy
-$139.59M
Q3 2026derivedN/M FY25 yoy
-$0.36
Q3 2026N/M FY25 yoy
$25.62M
Q3 2026−18.7% FY25 yoy
$382.51M
—
3.1×
—
-47.86%
—

Twelve months to Sep 30, 2026 · derived

Price

$3.8156.61%$4.97past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$84.28MFY 2025
$89.15M0FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$84,278,000reported
FY 20242024-12-31$89,149,000reported
FY 20232023-12-31$30,000reported
FY 20222022-12-31$1,316,000reported
FY 20212021-12-31$5,506,000reported

Segments

Revenue by Geography, FY2024 to FY2025FY2024United States · FY2024 · $7.26MRest of World · FY2024 · $81.89MFY2025United States · FY2025 · $72.19MRest of World · FY2025 · $12.09M
LineFY2025ShareChange
United States$72.19M86%+895.1%
Rest of World$12.09M14%−85.2%
Total$84.28M

From the 10-K filed Mar 9, 2026SPRY

Pharmaceutical preparations

ARS Pharmaceuticals, Inc. is the 106th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

ARS Pharmaceuticals, Inc. · CIK 1671858 · Engraved from SEC EDGAR